ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Research Opportunities In Pancreas Cancer Described; Top Priority Set

December 21, 1973

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

CCOP Application Now Total 180 Plus

November 26, 1982

NCCS Networker Volume 8 Issue 4, Winter 1994

January 13, 1994

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

Scientists should lobby Congress to support the project, Broad Institute Director Eric Lander says.

March 18, 2005